List of Axiron drug patents

Axiron is owned by Eli Lilly And Co.

Axiron contains Testosterone.

Axiron has a total of 7 drug patents out of which 0 drug patents have expired.

Axiron was authorised for market use on 23 November, 2010.

Axiron is available in solution, metered;transdermal dosage forms.

Axiron can be used as a method of transdermal administration of a physiologically active agent to a subject., a method of transdermally delivering testosterone, a method of increasing the testosterone blood level of a person in need thereof, a method of increasing the testosterone blood level of an adult male subject in need thereof.

The generics of Axiron are possible to be released after 27 September, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784878 ELI LILLY AND CO Transdermal delivery rate control using amorphous pharmaceutical compositions
Jul, 2023

(5 months from now)

US8993520 ELI LILLY AND CO Method and composition for transdermal drug delivery
Jun, 2026

(3 years from now)

US9180194 ELI LILLY AND CO Method and composition for transdermal drug delivery
Jun, 2026

(3 years from now)

US8807861 ELI LILLY AND CO Spreading implement
Feb, 2027

(4 years from now)

US8419307 ELI LILLY AND CO Spreading implement
Feb, 2027

(4 years from now)

US9289586 ELI LILLY AND CO Spreading implement
Feb, 2027

(4 years from now)

US8435944 ELI LILLY AND CO Method and composition for transdermal drug delivery
Sep, 2027

(4 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 23 November, 2010

Treatment: A method of transdermally delivering testosterone; A method of increasing the testosterone blood level of an adult male subject in need thereof; A method of transdermal administration of a physiologically active agent to a subject.; A method of increasing the testosterone blood level of a person in need thereof

Dosage: SOLUTION, METERED;TRANSDERMAL

How can I launch a generic of AXIRON before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic